MO - Altria Group, Inc.
62.20 -0.06 (-0.10%)
After hours: 7:50PM EDT
| Previous Close | 61.84 |
| Open | 62.00 |
| Bid | 62.01 x 1100 |
| Ask | 0.00 x 4000 |
| Day's Range | 61.69 - 62.50 |
| 52 Week Range | 53.91 - 74.38 |
| Volume | 5,076,783 |
| Avg. Volume | 6,801,228 |
| Market Cap | 117.371B |
| Beta | 0.44 |
| PE Ratio (TTM) | 11.18 |
| EPS (TTM) | 5.57 |
| Earnings Date | Oct 25, 2018 |
| Forward Dividend & Yield | 3.20 (5.16%) |
| Ex-Dividend Date | 2018-09-13 |
| 1y Target Est | 66.59 |
- CNBC•7 hours ago
FDA chief says agency is considering fast-track review for new e-cigs with tech to prevent youth use
The Food and Drug Administration may fast-track the review process for e-cigarettes that include features to make the products less likely to be used by kids, Commissioner Scott Gottlieb told CNBC on Thursday. The FDA ordered five brands — Juul, British American Tobacco's Vuse, Altria's MarkTen, Imperial Brands' Blu E-cigs and Japan Tobacco's Logic — to submit plans within 60 days detailing how they will prevent teens from using their products. The Food and Drug Administration is considering fast-tracking the review process for e-cigarettes that include features that make the products less likely to be used by kids, Commissioner Scott Gottlieb told CNBC on Thursday.
- Barrons.com•9 hours ago
Big Tobacco Still Has Pricing Power
Altria, like other tobacco stocks, has had a tough 2018, but it can still raise prices—a critical factor as sales volumes decline, argues Wells Fargo.
- Motley Fool•2 days ago
Is Altria Group a Buy?
The tobacco giant is facing a lot of obstacles in its path to growth.
- Market Realist•2 days ago
Why Analysts Are Recommending a ‘Buy’ for Altria Group
Can We Expect an Upside Potential in Altria Stock? Of the 16 analysts covering Altria Group (MO), 62.5% are recommending a “buy” as of September 17, while the remaining 37.5% are recommending a “hold.” None of the analysts are recommending a “sell.” That same day, analysts set an average price target of $66.59, which represents a return potential of 6.7% from the stock price of $62.44. Since the announcement of Altria’s second-quarter earnings on July 26, Stifel and Jefferies have both lowered their target prices.
- Market Realist•2 days ago
Analysts Expect Altria’s EPS to Rise in the Next Four Quarters
Can We Expect an Upside Potential in Altria Stock? For the next four quarters, analysts are expecting Altria Group (MO) to post EPS of $4.17, which represents a 10.6% growth from $3.77 in the corresponding four quarters of the previous year. EPS growth could likely be driven by revenue growth, expansion of net margins, and share repurchases.
- Market Realist•2 days ago
What Analysts Are Expecting for Altria’s Revenue
Can We Expect an Upside Potential in Altria Stock? For the next four quarters, analysts are expecting Altria Group (MO) to post revenues of $19.8 billion, which represents a 2.1% growth from $19.39 billion in the corresponding four quarters of the previous year. Altria is focusing on innovative product development and packaging, enhanced trade programs, and various marketing and promotional initiatives to drive sales.
- Market Realist•2 days ago
Can We Expect an Upside Potential in Altria Stock?
As of September 17, Altria Group (MO) stock was trading at $62.44, which represents a 7.9% rise since the announcement of its second-quarter earnings on July 26. On September 12, Scott Gottlieb, commissioner of the FDA, announced that the accelerating trajectory of flavored e-cigarette usage among youths has reached epidemic proportions. The e-cigarette market is dominated by JUUL, which had 72% of the market share as of mid-August, according to Wells Fargo analyst Bonnie Herzog.
- Zacks•3 days ago
What FDA's Stance on E-Cigarettes Means for Tobacco Stocks
The FDA announces directives to curb e-cigarette usage among youngsters. Though this caused tobacco stocks to gain recently, it is yet to be seen if the upside can be sustained.
- Motley Fool•4 days ago
Will Altria Sell Marijuana and Forget About E-Cigarettes?
Will the biggest domestic tobacco maker start a new cannabis business?
- Motley Fool•5 days ago
No, the FDA's Warning Was Not Good for E-Cigs
Among competing manufacturers, everyone loses if the FDA cracks down on the tobacco companies.
- Business Wire•6 days ago
FDA Accepts and Files U.S. Smokeless Tobacco Company’s Modified Risk Tobacco Product Application
U.S. Smokeless Tobacco Company, the U.S. smokeless tobacco industry leader, announced today that the U.S. Food and Drug Administration accepted and filed for substantive scientific review a Modified Risk Tobacco Product application for its moist smokeless tobacco product Copenhagen® Snuff Fine Cut.
- CNBC•6 days ago
HHS supports FDA's proposed e-cigarette crackdown, HHS Chief Azar says
Health and Human Services Secretary Alex Azar said the agency supports the Food and Drug Administration's proposed e-cigarette crackdown. The FDA earlier this week threatened to pull e-cigarettes from shelves if manufacturers do not control teen use. The FDA is specifically ordering five brands — Juul, British American Tobacco's Vuse, Altria's MarkTen, Imperial Brands' Blu E-cigs and Japan Tobacco's Logic — to submit plans within 60 days detailing how they will prevent teens from using their products.
- Simply Wall St.•7 days ago
Should You Be Worried When Altria Group Inc’s (NYSE:MO) Insiders Sell?
Altria Group, Inc., through its subsidiaries, manufactures and sells cigarettes, smokeless products, and wine in the United States. Altria Group’s insiders have divested from 3.17k shares in the large-cap stockRead More...
- Investopedia•7 days ago
Tobacco Stocks to Gain on FDA E-Cig Crackdown
The burgeoning popularity of e-cigarettes among young smokers has caused traditional cigarette industry players a great deal of trouble by eating into their market share. As regulators threatened to pull e-cigarettes from shelves if they do not address "widespread" teen use, shares of Altria Group Inc. ( MO), Philip Morris International Inc. ( PM), British American Tobacco Inc. ( BTI) and London-listed Imperial Brands, all closed up over 3%.
- Zacks•8 days ago
Altria (MO) in Focus: Stock Moves 6.7% Higher
Altria (MO) was a big mover last session, as the company saw its rise nearly 7% on the day amid huge volumes.
- Zacks•8 days ago
Altria (MO) Shares Up Close to 7% on FDA's Latest Notice
The FDA reveals serious enforcement actions related to the marketing and sale of e-cigarettes to minors, which may benefit tobacco players like Altria (MO).
- Market Realist•8 days ago
Why Did Tobacco Stocks Rally on September 12?
On September 12, Scott Gottlieb, the FDA commissioner, announced that the accelerating trajectory of flavored e-cigarette usage among youths has reached an epidemic proportion. The FDA is considering a policy change that would expel e-cigarette products from the market.
InvestorPlace•8 days ago3 Big Stock Charts for Thursday: Twitter, Danaher and Northern Trust
Another wave of bullishness from Advanced Micro Devices (NASDAQ:AMD) likely got the S&P 500 over the hump, with a helping hand from Altria Group (NYSE:MO). The memory maker was down following a downgrade from Goldman Sachs, and the parent company of Snapchat stumbled after BTIG Research suggested the stock could lose another 50% of its value over the course of the next twelve months. The top trading prospects for today are Twitter (NYSE:TWTR), Danaher (NYSE:DHR) and Northern Trust (NASDAQ:NTRS).
- ACCESSWIRE•8 days ago
Today's Research Reports on Trending Tickers: Altria Group and Philip Morris International
NEW YORK, NY / ACCESSWIRE / September 13, 2018 / U.S. markets were mixed on Wednesday as technology shares declined, dragging the Nasdaq into the red. The Dow Jones Industrial Average climbed 0.11 percent to close at 25,998.92, while the S&P 500 Index jumped 0.04 percent to close at 2,888.92. The Nasdaq Composite Index dropped 0.23 percent to close at 7,954.23.
Motley Fool•8 days agoWhy Altria Group, Galapagos, and Laredo Petroleum Jumped Today
Find out how an FDA ban could help one of these companies.
- Associated Press•8 days ago
Micron slumps while Altria and Chevron climb
Cigarette makers rose sharply after the Food and Drug Administration said it is looking at steps to combat "an epidemic" of e-cigarette use by teenagers. The company and its partner Galapagos said a rheumatoid arthritis drug met its goals in a late-stage study. Energy companies and oil prices continued to rise Wednesday with the price of crude.
Associated Press•8 days agoMarkets Right Now: US stocks end mostly flat on Wall Street
NEW YORK (AP) — The latest on developments in financial markets (all times local):
- Motley Fool•8 days ago
Crackdown on E-Cigarettes Pushes Shares of Altria Group 7% Higher Wednesday
The FDA's announcement that teen usage of e-cigarettes has reached frightening levels has traditional tobacco companies surging Wednesday.
- Barrons.com•8 days ago
The FDA Is Cracking Down on E-Cigarettes, and That’s Good News for Tobacco Stocks
The FDA is considering taking a more aggressive approach toward cubing e-cigarette use, and tobacco stocks are jumping.
- Bloomberg Video•2 days ago
How Oppenheimer's Rosin Is Trading Altria Group
Sep.18 -- Alon Rosin, Oppenheimer head of institutional equity derivatives, discusses his options strategy with Bloomberg's Julie Hyman on "Bloomberg Markets: The Close."
